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1  Introduction
The use of textiles in medicine has a long tradition. An
important field of application is in wound care and pre-
vention of chronic wounds [1]. Among the long list of tex-
tile materials, bandages and wound dressings gained
great popularity [2]. The exploitation of textile materials
was supported by availability, prices and re-usability [3].
Along with the technological development of functional
textiles, their use in wound healing and prevention of
chronic wounds has reached a new quality of interactiv-
ity between biological tissues and textiles [2]. These fi-
bres were shown to favour wound occlusion, exudate
transport and drug release with much reduced distress to
the patient [1]. Despite the fact that natural textiles ful-
filled primary quality approaches, such as biocompatibil-
ity, flexibility and strength, there is an increasing need for
specified functions [4]. In particular, the controlled re-
lease of bioactive molecules to counteract the progres-
sion of infection and inflammation, such as in chronic
wound management, was considered a step forward in
this research area [5]. The local delivery of drugs by top-
ical administration or a delivery device may enable the
maintenance of a high local drug concentration for an ex-
tended period without reaching systemic toxicity. This is
an important feature because the use of anti-inflamma-
tory drugs, such piroxicam, which is a non-steroidal anti-
inflammatory drug (NSAID), is very useful to counteract
local inflammation, although it can be absorbed through
blood vessels and could result in severe side effects for
both the gastrointestinal tract and kidneys[6]. Thus, the
topical administration of NSAIDs can control these se-
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vere side effects. Besides this advantage over conven-
tional oral and intravenous dosage forms, topical drug de-
livery offers many other benefits, such as first pass me-
tabolism avoidance, pain minimisation and patient com-
pliance [7].
Controlled delivery dressings can provide an excellent
means of delivering drugs to wound sites in a consistent
and sustained manner over long periods of time without
the need for frequent dressing changes[8].Therefore,
there is a need to develop new dressings that are useful in
the treatment of local infections, where increasing the lo-
cal concentrations of anti-inflammatory drugs may be
beneficial, while avoiding high systemic doses; thus re-
ducing patient exposure to an excess of drug beyond that
required at the wound site [9, 10]. Furthermore, a dress-
ing that delivers an active substance to a wound site in a
controlled fashion for a sustained period of about a week
could help solve or minimise issues associated with non-
compliance patients.
Several biodegradable devices from both natural and
synthetic polymers have been produced by different
processes in recent years for use as drug carriers.
Biodegradable polymers can release larger quantities of
pharmaceutical agents and their degradation properties
can be tailored for a specific application [11]. Natural poly-
mers, such as proteins, are attractive, since they exhibit
superior biocompatibility and biodegradability [12]. Re-
cently, proteinaceous microspheres were developed that
incorporated different oils to control the high levels of
elastase produced in chronic wounds [13]. Due to its in-
volvement in such process, there is extensive literature
exploring different types of inhibitors or inhibitor formula-
tions that may restore the normal levels of this enzyme
[14]. To the best of our knowledge, anti-inflammatory
drugs have been attached onto cotton fibres [15], but nev-
er in combination with oils.
In the present work, piroxicam, sonochemically en-
trapped to bovine serum albumin (BSA) microspheres,
was attached to cotton and non-woven gauzes to produce
a functionalised biomaterial with the ability to deliver the
pharmaceutical agent in a controlled manner. Moreover,
the wound-healing ability of these materials was tested
on 3D human skin equivalents.
2  Materials and methods
2.1  Materials
Piroxicam was acquired from Sigma (Spain), along with-
polyvinyl alcohol (PVA; MW = 30 000–70 000 Da, 87–90%
hydrolysed) and BSA. The centricon tubes (molecular-
weight cutoff of 100 kDa, Amicon) were purchased from
Amicon.
The sterilised gauzes fibres were commercially avail-
able from a local pharmacy (100% cotton gauze and non-
woven gauze composed of 67% viscose and 33% poly-
ester).
Human full-thickness skin equivalents (EpidermFT)
were supplied by MakTek Corporation (USA). All other
reagents were of analytical grade and purchased from
Sigma (Spain).
2.2  Equipment
The experimental setup used was composed of a probe-
type ultrasound source (20kHz Sonics & Materials Vibra-
cell CV 33) fitted with a 3mm diameter titanium micro-tip.
Power delivery was controlled as percentage amplitude.
The reaction vessel was an open glass cell (diameter
19mm, height 75mm), which contained 16mL of sample
solution. The sonochemical reactor temperature was con-
trolled by a thermostated water bath with a freezer ex-
changer placed within a thermo jacket cell; this gave a
steady operating temperature of (10 ± 1)°C. The tempera-
ture was monitored throughout using K-type thermocou-
ples.
2.3  Sonochemical preparation of proteinaceous
microspheres
Microspheres, with NSAID, were synthesised by an
adaptation of the Suslick method [16].Piroxicam
(3000 µM) was added to protein solution (5 g L–1) and lay-
ered with vegetable oil. The very low solubility of piroxi-
cam required the use of dimethylsulfoxide/water solu-
tions (1:99 v/v). Finally, the surfactant, used as stabiliser,
was dissolved in the aqueous phase. The bottom of the
high-intensity ultrasonic horn was positioned at the
aqueous/organic interface, employing an amplitude of
40% with a temperature of (10 ± 1)°C and with a total
treatment time of 3 min. The separation of phases was
accomplished in a few minutes, due to the lower density
of microspheres, relative to the density of water. Howev-
er, to obtain complete separation of the proteinaceous
microspheres from the mother solution, the flasks were
placed in a refrigerator (4°C) for 24 h. Microspheres were
later collected by centrifugation (2000 g, 30 min) using
the centricon tubes.
2.4  Microsphere characterisation parameters
2.4.1  Determination of microsphere yield
The efficiency of microsphere formation was determined
by the Lowry method [20], using BSA as a standard. This
method was based on the quantification of protein in the
supernatant. The efficiency of microsphere formation was
calculated from Eq. (1):
(1)
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in which [p]
total
and [p]
supernatant
are the initial and final
protein concentrations in the aqueous solution, respec-
tively. This process indicates the percentage of protein
that formed microspheres in relation to the total amount
used during preparation.
Measurements were recorded in triplicate and the re-
sults were expressed as mean value ± standard deviation
(SD).
2.4.2  Determination of size and zeta-potential
The size distributions and zeta-potentials of the micros-
pheres were determined at (25.0 ± 0.1)°C using a Malvern
zetasizer NS (Malvern Instruments) by photon correlation
spectroscopy (PCS) and electrophoretic laser Doppler
anemometry, respectively. The proteinaceous micros-
pheres were diluted in phosphate-buffered saline (PBS)
1:100. The results were expressed as mean value ± SD.
2.4.3 Entrapment efficiency of piroxicam
The entrapment efficiency of piroxicam in proteinaceous
microspheres was measured by UV spectrophotometry at
353 nm. The separation of free piroxicam was achieved by
centrifugation of samples at 1500 g for 30 min, using cen-
tricon tubes. The entrapment efficiency of piroxicam was
obtained from Eq. (2):
(2)
in which [piroxicam]
initial
is the initial concentration used
and [piroxicam]
final
is the final concentration in the super-
natant.
2.5  Chemical activation of gauzes
2.5.1  Cationisation of cotton and non-woven gauzes
The gauzes were cationised using the exhaust method as
described in [17]. Cationisation was performed in sealed,
stainless-steel pots with 120cm3 capacity in a laboratory-
scale dyeing machine (AHIBA Spectradye, from Datacol-
or International) with IR temperature control.
The treatment was carried out using a material/liquor
ratio of 1:20, 10% (on weight of the fabric) of poly(diallyl-
dimethylammonium chloride) (PDDA) and 5.0 g L–1 of
sodium hydroxide over 60 min at 50°C. Then the gauzes
were washed thoroughly with distilled water.
2.5.2  Determination of the cationisation efficiency on
the gauze surface
Cationisation at the surface of gauzes (cotton and non-
woven) was analysed by staining of treated samples and
controls (cotton and non-woven gauzes without cationi-
sation treatment) with Comassie brilliant blue G250 (Acid
Blue 90; C.I. 42655). The staining was executed in an AHI-
BA machine using 1 g L–1 of Comassie dye, at 60°C for
Entrapment (%)
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60 min. After staining, the samples were washed with dis-
tilled water until no more dye could be detected in the
washing solution. Colour measurements were deter-
mined using a spectrophotometer (illuminant D
65
at
600nm; Spectraflash, from Datacolor International) cou-
pled to a computer. The colour strength was evaluated as
K/S (Eq. 3) at the maximum absorption wavelength
(600 nm). The ratio between the absorption (K) and scat-
tering (S) coefficients is related to reflectance data by ap-
plying Kubelka–Munk’s law at each wavelength, and it is
proportional to dye concentration [18, 19]. R is the light re-
flection. For all types of gauze samples, experiments were
performed in triplicate.
(3)
2.6  Attachment of proteinaceous microspheres,
containing piroxicam, onto gauze bandages
To attach proteinaceous microspheres containing piroxi-
cam to the gauzes (0.1g), two sets of experiments were
applied, namely, silent (incubation) and sonochemical
methods. The attachment of microspheres by incubation
was carried out in two different steps. Firstly, the micros-
pheres were produced and submitted to an extensive
physico-chemical characterisation. They were later incu-
bated with the gauzes in a water shaking bath at room
temperature (25°C) for 24 h under constant shaking
(50 rpm). Several controls were run simultaneously: a con-
trol test with non-cationised gauzes (cotton and non-wo-
ven) and a control test with cationised gauzes (cotton and
non-woven) without microspheres, incubated with PBS,
0.01 M (pH = 7.4). After incubation, the samples were re-
moved and washed with distilled water.
Secondly, attachment of proteinaceous microspheres
by the sonochemical method was performed in a one-step
reaction. In this case, the gauzes were added to the bipha-
sic system, consisting of protein solution and vegetable
oil, by applying the same conditions previously described.
The control samples were gauzes (cotton and non-woven,
cationised and non-cationised) in PBS submitted to ultra-
sound treatment under the same conditions. The remain-
ing solution was centrifuged, using centricon tubes, and
the protein concentration in the supernatant and the
amount of piroxicam entrapped was determined. Finally,
the sample gauzes were collected and washed with dis-
tilled water. All measurements were performed in tripli-
cate.
2.7  Evaluation of proteinaceous microspheres
attached to gauzes based on the ninhydrin
reaction
The presence of protein microspheres in the gauze sam-
ples was evaluated using ninhydrin (2,2-dihydroxyin-
K
S
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ferent microsphere concentrations added to fresh culture
medium as well as to different control solutions (BSA so-
lution; piroxicam solution).
After incubation, the cells were washed in PBS (1×)
and RNA was isolated from cell cultures, according to the
SV Total RNA isolation system protocol from Promega.
The quality and concentration of RNA samples were eval-
uated using a Nanodrop Spectrophotometer before con-
version to cDNA using the high-capacity cDNA reverse
transcription kit (BIO-RAD) with thermal cycling condi-
tions running for 5 min at 25°C, 30 min at 42°C and 5 min
at 85°C. The anti-inflammatory effect of the proteinaceous
microspheres was evaluated as the ability to downregu-
late the gene expression of cox-2 in human skin fibrob-
lasts by real-time PCR. Taqman Universal Master Mix II
and the predesigned/preformulated primer and probe
sets, TaqMan Gene Expression Assays, were purchased
from Applied Biosystems (California, USA). The ∆∆Ct
method was applied using mitochondrial ATPase6 as the-
housekeeping gene. PCR amplification was performed ac-
cording to the manufacturer’s instructions on a CFX96
Touch Real-Time PCR Detection System (Bio-Rad Labora-
tories Hercules, CA 94547).
2.11  Wound-healing assay
Tissues were cultured at the air-liquid interface in tissue
culture inserts placed in six-well plates. Upon receipt, the
tissues were placed into new six-well plates containing
2.5 mL of fresh culture medium and kept at 37°C, 5% CO
2
overnight. Burn wounds were obtained by placing a
cautery on top of the tissue for 10 s. The gauze samples
were place on top of the tissue covering the wounded
area. Two burn wounds per tissue were done to control
the wound size and healing was evaluated in two inde-
pendent assays. Skin equivalents without functionalised
gauzes and treated with a commercial collagen dressing,
Suprasorb C (Lohmann & Rauscher, Germany), were used
as controls.
Healing was evaluated over a period of six days and
the tissues were then evaluated histologically. Skin equiv-
alents were fixed in 4% formaldehyde solution at room
temperature. Afterwards, paraffin-embedded tissue sec-
tions 4 µm thick were obtained and stained with haema-
toxylin and eosin by a standard protocol. All sections were
observed under a light microscope (Olympus IX71).
3  Results and discussion
3.1  Attachment of proteinaceous microspheres,
containing piroxicam, to cotton and non-woven
gauzes
Considering the special advantages and high potential for
the application of microstructured materials in the textile
dane-1,3-dione) reagent. Ninhydrin is most commonly
used to detect terminal amines or lysine residues in pep-
tides and proteins [18]. When reacting with these free
amines, a deep blue or purple colour, known as Ruhe-
mann’s purple, is produced.
For this assay, the gauzes were dried at 60°C and then
incubated with ninhydrin solution (0.5%), at 60°C, for
30 min. This test was performed on the samples after pro-
teinaceous microsphere attachment by incubation and
ultrasound treatment, and on control gauzes (cotton and
non-woven samples gauzes, cationised and non-
cationised without microspheres).
2.8  Scanning electron microscopy (SEM) analysis
SEM images were obtained with a scanning electronic
microscope (NOVA Nano SEM 200, FEI) with detection of
backscattered and secondary electrons. The samples
were previously gold coated in vacuum.
2.9  Quantification of piroxicam released from
proteinaceous microspheres attached to gauze
bandages
The release of piroxicam by the microspheres attached
to gauzes was examined by incubation of the textile
samples, and control samples (gauzes without micros-
pheres) in distilled water (pH 5.5). The distilled water
was used to mimic skin pH (5.5–5.6) [20]. At determined
time points, aliquots were taken and piroxicam release
was monitored by absorbance measurements at 353nm
using a Heλios γ ThermoSpectronic spectrophotometer
(Unicam). The quantification of piroxicam released was
established by a piroxicam standard absorbance curve.
The release studies were carried out in triplicate and for
a period of 6 days. Results are reported as mean value
±SD.
2.10  Evaluation of the anti-inflammatory effect of
microspheres applied to human skin
fibroblasts
Normal human skin fibroblasts (cell line BJ-5ta) were pur-
chased from the American type culture collection (ATCC).
The cells were maintained according to ATCC recom-
mendations (4 parts of Dulbecco’s modified Eagle’s medi-
um containing 4 mM L-glutamine, 4.5 g L–1 glucose,
1.5 g L–1 sodium bicarbonate and 1 part of Medium 199,
supplemented with 10%(v/v) of fetal bovine serum,
1%(v/v) penicillin/streptomycin solution and 10 µg mL–1
Hygromycin B). The cells were maintained at 37°C in a
humidified atmosphere of 5% CO
2
. Culture medium was
refreshed every two to three days. Cells were seeded at a
density of 10 × 103cells/1000 µL/well on 12-well tissue cul-
ture polystyrene (TCPS) plates (TPP, Switzerland). One
day after seeding, the cells were exposed over 24 h to dif-
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industry, especially for producing high-performance bio-
medical textiles, this study reports the application of
 microstructured proteinaceous material containing an
anti-inflammatory drug for biomedical applications.Two
different methods, silent (incubation) and sonochemical
treatments, were used to attach BSA microspheres, con-
taining the anti-inflammatory drug, to cotton and non-
 woven gauzes.
For the silent methodology, the microspheres were
previously prepared and characterised.
In our previous work, matrices based on BSA protein
were produced and characterised [21]. Briefly, the char-
acterisation results presented earlier indicated that small-
er sizes were obtained with 95:5 aqueous/organic phase
and 8% stabiliser. The proteinaceous microspheres ob-
tained were spherical, homogeneous particles with
smooth surfaces [21]. The efficiency of microsphere for-
mation was determined with the Lowry assay [22],result-
ing in about 100% yield. Furthermore, the results showed
high entrapment efficiency (≈80%) of piroxicam in BSA
microspheres. These proteinaceous microspheres, con-
taining piroxicam, had a Z-average value of (300 ± 20) nm
with a particle size distribution, determined as a polydis-
persity index (PDl), of 0.045 ± 0.001. The previous results
also demonstrated that these particles had a zeta-poten-
tial of around (–5 ± 0.9) mV, indicating the presence of
negative charges distributed on the surface of the mi-
crospheres. Moreover, the stability results proved that
BSA microspheres were stable for at least two months,
since the Z-average and the zeta-potential measurements
gave almost the same values. Therefore, these conditions
were used as standard conditions for this study.
After this extensive characterisation, the protein mi-
crospheres were incubated with gauzes (cationised and
non-cationised) in a shaking water bath, at 25°C and
50 rpm.
In another set of experiments, the attachment of mi-
crospheres was carried out in a one-step reaction using
the ultrasound system. This attachment procedure did
not lead to significantly different physico-chemical char-
acteristics of BSA microspheres containing piroxicam.
The efficiency of microsphere formation was about 100%
and the entrapment efficiency of piroxicam was around
76%. The higher entrapment efficiency can be explained
by their sparing solubility in water due to drug–albumin
interactions. Indeed, piroxicam revealed a higher parti-
tion capacity in liposomes and consequently present a
higher K
p
value [23]. Additionally, location studies in the
lipidic layer showed that piroxicam could be positioned
with the hydrophilic part oriented toward the polar part of
the membrane and the hydrophobic segment in the upper
part of the lipophilic tails [23]. Thus, piroxicam must be
aligned between the albumin molecules in the protein lay-
er and inside the microspheres. Piroxicam entrapment ef-
ficiency is an important factor because the release rate is
usually dependent on the drug concentration gradient
[24]. Furthermore, higher levels of drug incorporation lead
to a wider concentration gap between the polymeric mi-
crospheres and the release medium and can cause a high-
er diffusion rate.The values of zeta-potential were also
very similar ((–5 ± 0.5) mV), as well as the Z-average and
PDl values ((280 ± 10) nm and 0.065 ± 0.001, respectively).
Taking into account that microspheres have a nega-
tive surface charge, our aim was the activation of the sur-
face of the gauzes to obtain a positive charge. Conse-
quently, greater electrostatic interactions between the
negative surface charge of BSA microspheres and the
positive surface charge of the gauzes was expected.
The addition of cationising products to cotton is used
extensively to improve anionic dye fastness [25]. This
study reports not only the cationisation of cotton gauzes,
but also of the non-woven gauzes using PDDA. The qua-
ternary ammonium group, +N(CH
3
)
3, 
has a very high pos-
itive charge and can thereby lead to the formation of ion-
ic bonds (salt linkages) with negatively charged anionic
groups, such as those found in a wide array of anionic dye
classes or carboxyl-containing compounds [26]. The rea-
son to submit the non-woven gauze to cationisation is
due to the presence of viscose (67%), containing hydrox-
yl groups,in the cotton fibre. These hydroxyl groups ac-
quire a negative charge when they are ionisable, de-
creasing the electrostatic interactions with the BSA mi-
crospheres and thus the need for cationisation of the
gauzes.
The cationised and control samples (cotton and non-
woven gauzes not cationised) were dyed with Comassie
blue, a known acid dye, to evaluate the cationisation effi-
ciency. When dyed, ionic bonding with fibre cationic sites
accounts for the fixation of coloured anions in the dyed
material. The efficiency of the cationisation process was
determined based on colour strength (K/S) (Table 1). Com-
paring the K/S values of the cationised and the non-
cationised gauzes (cotton and non-woven), it is possible
to conclude that Comassie dye has greater affinity for the
cationised fibre than that of the non-cationised fibre,
demonstrating the strong electrostatic interactions be-
tween the negative charge of dye molecules and the pos-
itive charge present at the gauze surfaces.
Table 1. K/S values (λ = 600nm) for the cationised samples (cotton and
non-woven gauzes represented as CO cat and NW cat, respectively) and
the control samples (non-cationised cotton and non-woven gauzes, repre-
sented as CO control and NW control, respectively) dyed with Comassie
brilliant blue G250. K/S was calculated according to Eq. (3). Values report-
ed are the mean ± SD of at least three different batches of each micros-
phere formulation attached to gauze bandages
Samples K/S
CO (control) 1.51 ± 0.3
CO cat 23.8 ± 0.9
NW (control) 1.8 ± 0.5
NW cat 25.0 ± 0.7
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The proposed methods to attach piroxicam-loaded
BSA microspheres to cotton and non-woven gauze band-
ages (cationised and non-cationised) were evaluated us-
ing ninhydrin. After 30 min of reaction, a colour change in
the gauze bandages from light yellow to purple was ob-
served, indicating reaction between the protein micros-
pheres and ninhydrin. It is known that ninhydrin reacts
with amino acids or proteins to generate a visible purple
colour in the presence of amines [18].
Figure 1 depicts the development of a blue colour, in
all samples (cationised and non-cationised), confirming
the presence of protein at the surface of the gauzes.
These results suggest, however, a more pronounced blue
colour for the cationised samples, evidencing greater
protein attachment to the positively charged surfaces.
Furthermore, ultrasound treatment seems to promote
more uniform protein transfer from solution to the gauze
surface, which translates to more uniform colour devel-
opment.
3.2  Morphology of gauze bandages with
microspheres
Morphological analysis of the fibres was carried out by
SEM, which enabled qualitative 3D imaging of surface
features. It is clearly illustrated that, with either method-
ologies, it was possible to attach BSA microspheres, con-
taining piroxicam, to the cotton and non-woven gauzes
(Fig. 2).The images also suggest that the presence of pos-
itive charges on the surfaces of the gauzes result in mi-
crospheres attachment because it is possible to visualise
a layer of microspheres almost completely covering the
surface of the gauze fibres. These data corroborate the
ninhydrin results.
3.3  In vitro release profile of piroxicam from cotton
and non-woven gauze bandages
The release behaviour of polymeric microspheres is one of
the most important features of drug/polymer formulations
for sustained drug delivery. The release profile of BSA-
based particles was thus studied (Fig. 3) for wet gauze
bandages (immediately after ultrasound or incubation
treatment) and dried gauze bandages (samples dried at
room temperature).
The release profiles shown have two distinct patterns:
an accentuated initial burst of release during the first 6h
followed by a stagnant phase of release for the remaining
time. The burst of piroxicam is associated with piroxicam
molecules dispersing close to the surface of the micros-
pheres, which diffuse outwards at the beginning of incu-
bation (Fig. 3).The release of a compound from a matrix is
governed by several factors, such as the nature and size
of the particles and also the nature of the compound be-
ing entrapped. From the SEM results discussed previous-
ly, it was concluded that ultrasound produced a higher
content of proteinaceous microspheres. The results show
that the BSA particles prepared by ultrasound released
more piroxicam (Fig. 3); this can be attributed to the fact
that, in liquid media, ultrasound enhances mass transport
of constituents (protein microspheres) in a non-homoge-
neous fashion, allowing efficient attachment to the gauze
fibres. The beneficial use of ultrasound is realised through
its chemical, mechanical or physical effects on the
process or product [27]. Conversely, attachment by incu-
bation with constant stirring is not sufficient to promote
efficient treatment, which can explain the lower release of
piroxicam. The amount of piroxicam released can be
 correlated with the quantity entrapped in microspheres
effectively attached to the surface of the fibres.
Incubation and ultrasound treatment with the charac-
teristics described appear to yield the same release pro-
filesforpiroxicam from cationised gauze bandages (Fig. 3).
Figure 1. Images of colour developed after 30 min of ninhydrin applica-
tion on the microspheres attached to cotton and non-woven gauze band-
ages by sonication or incubation methods (cotton and non-woven gauzes
represented as CO and NW, and cotton and non-woven gauzes cationised
represented as CO cat and NW cat, respectively). The control samples
were incubated or sonicated with PBS (non-cationised gauzes: cotton and
non-woven without microspheres, denoted CO control and NW control,
respectively; cationised gauzes: cotton and non-woven without micros-
pheres, denoted CO cat control and NW cat control, respectively).
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Figure 3. In vitro release profiles of piroxicam entrapped in BSA microspheres from cotton and non-woven gauzes bandages: incubation treatment (A, B)
sonochemical treatment (C, D). Each point represents the mean ± SD values from three different batches. The inset values show the release profile over
the first 6h.
Figure 2. SEM images(magnification of
5000x) of cotton gauzes and non-woven
bandages.
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As stated, the cationisation process promotes the pres-
ence of positive charges on the gauze surface that favour
the attachment of BSA microspheres, which have a nega-
tive surface charge, to the structure of the gauze material
(cotton and non-woven). Therefore, the promotion of elec-
trostatic interactions between the microspheres and the
cationised gauzes can lead to increased release of piroxi-
cam. These data also indicate the lowest concentration of
piroxicam released from dry gauze bandages. This result
can be attributed to the fact that the drying process can
induce premature disruption of BSA microspheres and,
consequently, a lost in piroxicam content. It is also neces-
sary to note that, in dried samples, hydration of the textile
material may be more difficult or slower and, consequent-
ly, the diffusion of piroxicam to the medium may be de-
creased.
Interestingly, gauze porosity has a significant influ-
ence on BSA microsphere attachment, affecting the drug-
delivery concentrations. The results show that,indepen-
dent of the methodology used to immobilise the BSA mi-
crospheres, the non-woven gauze releases more piroxi-
cam over time. In this way, being more closed and
compact than cotton gauzes, this type of fibre structure
can offer better support for the attachment of micros-
pheres.
3.4  Anti-inflammatory properties and wound
healing
The biocompatibility of piroxicam entrapped in proteina-
ceous devices was previously tested [21] and identified
the range of concentrations (75–300 mg L–1) as non-cyto-
toxic for two cell types, including BJ-5ta.
In this study, the anti-inflammatory potential of these
particles, containing piroxicam, was confirmed. It is well
known that the action of NSAIDs is mediated by its ca-
pacity to inhibit cyclo-oxygenase (COX) activity, in par-
ticular, an inducible isoform (COX-2), found in areas of in-
flammation and in the brain [28]. It has been suggested
that the anti-inflammatory actions of NSAIDs are due to
the inhibition of COX-2, whereas unwanted side effects
are due to the inhibition of COX-1 [29]. For this reason, ex-
pression of the cox-2 gene was examined in human skin
fibroblasts (BJ-5ta) in the presence of microspheres, con-
taining or lacking piroxicam.
Figure 4 shows relative cox-2 gene expression in the
presence of proteinaceous microspheres containing
piroxicam (PM+Px) at two different concentrations, mi-
crospheres without piroxicam (PM) and a control solution
of soluble BSA and different concentrations of piroxicam.
All piroxicam solutions decreased the levels of relative-
cox-2 gene expression as expected;the highest concen-
tration of piroxicam (180 µM equivalent to the maximum
amount encapsulated) is the most effective. The physical
process of microsphere formation has some influence on
the anti-inflammatory capacity of the isolated compo-
nents. PMs with piroxicam have less anti-inflammatory
effect than the isolated components at similar concentra-
tions; the opposite is true for PMs without piroxicam. The
data demonstrates for this cell model that these materials
have the ability to reduce the inflammation process me-
diated by COX-2 in human fibroblasts to levels similar to
those found in the control experiment.
The biocompatibility of any material should also be as-
sessed by exposing THP-1 human macrophages to it and
evaluating the production and release of the pro-inflam-
matory cytokine TNF-α. Preliminary results suggested
that functionalised gauze bandages induced the produc-
tion of low levels of TNF-α protein after 48 h of incubation
(data not shown).
To determine if the different materials affected the ki-
netics of wound healing differently, the materials were ap-
plied, wet, on top of the skin equivalents immediately af-
ter the burn wounds were inflicted and histological analy-
sis was performed six days later.
Optimisation of the attachment of proteinaceous par-
ticles to gauze bandages was achieved with ultrasound.
Therefore, functionalised samples prepared with ultra-
sound were analysed for their capacity to promote wound
healing.
Epidermal regeneration of a wound is a complex
process in which residual epithelial cells proliferate in an
integrated manner to form an intact epidermis. In burns,
a number of epithelial cells survive in hair follicles and
Figure 4. Relative cox-2 gene expression, measured by real-time PCR, in
the human fibroblast cell line BJ5ta in the presence of different concentra-
tions proteinaceous microspheres, containing piroxicam, (PM+Px
300 mg L–1; PM+Px 150 mg L–1); protein microspheres without piroxicam
(PM 300 mg L–1); BSA solution; different piroxicam concentrations (10; 40
and 180 µM) and in the presence of interleukin 1-beta (IL-1β). Results
show the mean values of two replicates from two experiments carried out
independently.
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sweat glands. Prevention of infection is the primary aim
of the treatment of burn wounds to allow for the optimal
regeneration of lost cells. Thus, a moist environment is
best for epithelialisation and wound healing [30].
Figure 5 shows that it is possible to observe the archi-
tecture and relative size in histological sections of the
wounds six days post-wounding. The results revealed
that the proteinaceous microspheres, containing piroxi-
cam and applied to cotton and non-woven gauzes, in-
duced cell proliferation and migration to the wound site,
especially for wounds treated with cationised gauzes. The
results obtained are comparable with those for the com-
mercial collagen dressing; Suprasorb C, used for several
types of wounds, including burn wounds.
Macroscopic observations of the wounds indicate that
the control samples (Fig. 5A) are characterised by the lack
of epithelium and the dermis is covered with a crust from
burning. Six days later, the crust had disappeared from
the control sample (Fig. 5B) and samples exposed to dif-
ferent materials showed healing (Fig. 5C–F).
Moreover, wounds in contact with gauzes induced cell
proliferation and migration (most probably keratinocytes
and fibroblasts) from the margins to the wound core,
which would result in faster re-epithelisation and wound
closure.
During the healing of an acute wound, re-epithelisa-
tion occurs from the margin to its core. Therefore, the re-
sults indicated that wound size reduction was greater in
the cationised non-woven gauze sample even when com-
pared with the commercial control (Suprasorb C). Histo-
logical examination was done with the section obtained
in the centre of wound. Thus, the results reflect the heal-
ing improvement promoted by contact with the BSA mi-
crospheres, containing piroxicam, attached to the
gauzes.
From the histological results obtained, it can also be
noted that wounds healed in contact with BSA micros-
pheres, attached or not to cationised gauzes, were almost
completely closed and covered with new epithelium,
which was not the case for the controls.
The characterisation of the non-woven gauzes ob-
tained by cationised treatment suggested that these offer
greater availability of microspheres for the wound-healing
process.
It has been proposed that NSAIDs can result in a mod-
est inhibition of the initial inflammatory response and its
symptoms [31]. Recent studies also demonstrated that the
use of vegetable oils in protein formulations had the abil-
ity to reduce the activity of elastase [13]. Nevertheless, the
inclusion of both NSAID and vegetable oil in the micros-
phere’s composition and attachment to gauzes was ex-
ploited for the first time, allowing us to develop a novel
wound dressing for biomedical applications.
4  Concluding remarks
This study demonstrates the capacity of proteinaceous
microspheres, containing an anti-inflammatory drug, to
become attached to different gauzes, cotton and non-wo-
ven. The continuous application of shear stress within the
bulk solution from the mixing effect provided by stirring
or ultrasound waves was able to promote the attachment
of BSA particles to gauze bandages. Furthermore, the
chemical activation of gauzes, using PDDA as a cationis-
ing reagent, improved the content of BSA microspheres
Figure 5. Histological cross-sections of
wound burnsstained with haematoxylin/
eosin, in which (A) is the wound imme-
diately after the burn, t = 0 (control); (B)
is the wound after six days without any
treatment (control); (C) is the wound
with Suprasorb C after six days (control);
(D) is the wound with microspheres
 after six days; (E) is the wound with
 microspheres on NW cat after six days,
and (F) is the wound with microspheres
on CO cat after six days.
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at the surfaces of the fibres and, consequently, a higher
concentration of piroxicam was released. However, most
drug was released when the attachment process was per-
formed by the sonochemical method. The short treatment
time (3 min) improves the mass transport effects by en-
hancing attachment of the microspheres. The promotion
of attachment of the microspheres to gauzes using ultra-
sound was achieved by a one-step reaction, signifying a
reduction in product consumption, shorter process time
and a greater uniformity of treatment.
The release of piroxicam entrapped in BSA micro -
spheres was dependent on the structure of the gauze. The
fastest and highest concentration of piroxicam released
was reached when the proteinaceous microspheres were
attached to non-woven gauzes. Moreover, dermal burn
healing experiments using human skin equivalents
showed that the application of our material accelerated
re-epithelisation and wound closure.
The results achieved indicate that these function-
alised gauze bandages may potentially be used as power-
ful bioactive carriers for wound healing. Furthermore,
such drug carriers can be helpful for several pathologies
where the bioactivity of piroxicam is expected to be ther-
apeutically relevant.
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